Skip to main content

and
  1. Article

    Open Access

    The marine-derived HIF-1α inhibitor, Yardenone 2, reduces prostate cancer cell proliferation by targeting HIF-1 target genes

    Prostate cancer (PCa) ranks as the second most prevalent cancer in men, with advanced stages posing significant treatment challenges. Given its solid tumor nature, PCa is highly susceptible to hypoxia, a condi...

    Siyong Peng, Yingbo Guo, Marie Irondelle in Cellular & Molecular Biology Letters (2024)

  2. No Access

    Article

    Plasmatic osteopontin and vascular access dysfunction in hemodialysis patients: a cross-sectional, case–control study (The OSMOSIS Study)

    Despite close follow-up of patients with native arteriovenous fistulas (AVFs), up to 10% experience thrombosis each year. The OSMOSIS Study (Osteopontin as a Marker of Stenosis) tested the hypothesis that the ...

    Julie Contenti, Matthieu Durand, Sandor Vido, Serge Declemy in Journal of Nephrology (2022)

  3. Article

    Open Access

    Plk1, upregulated by HIF-2, mediates metastasis and drug resistance of clear cell renal cell carcinoma

    Polo-like kinase 1 (Plk1) expression is inversely correlated with survival advantages in many cancers. However, molecular mechanisms that underlie Plk1 expression are poorly understood. Here, we uncover a hypo...

    Maeva Dufies, Annelies Verbiest, Lindsay S. Cooley in Communications Biology (2021)

  4. Article

    Open Access

    Hypoxia protects against the cell death triggered by oxovanadium–galactomannan complexes in HepG2 cells

    Polysaccharides from various sources have been used in traditional medicine for centuries. The beneficial pharmacological effects of plant-derived polysaccharides include anti-tumor activity.

    Monique Meyenberg Cunha-de Padua in Cellular & Molecular Biology Letters (2019)

  5. Article

    Open Access

    The energy disruptor metformin targets mitochondrial integrity via modification of calcium flux in cancer cells

    Mitochondrial integrity is critical for the regulation of cellular energy and apoptosis. Metformin is an energy disruptor targeting complex I of the respiratory chain. We demonstrate that metformin induces end...

    Camille Loubiere, Stephan Clavel, Jerome Gilleron, Rania Harisseh in Scientific Reports (2017)

  6. Article

    Open Access

    Knockout of Vdac1 activates hypoxia-inducible factor through reactive oxygen species generation and induces tumor growth by promoting metabolic reprogramming and inflammation

    Mitochondria are more than just the powerhouse of cells; they dictate if a cell dies or survives. Mitochondria are dynamic organelles that constantly undergo fusion and fission in response to environmental con...

    M. Christiane Brahimi-Horn, Sandy Giuliano, Estelle Saland in Cancer & Metabolism (2015)

  7. No Access

    Article

    AmotL2 disrupts apical–basal cell polarity and promotes tumour invasion

    The establishment and maintenance of apical–basal cell polarity is essential for the functionality of glandular epithelia. Cell polarity is often lost in advanced tumours correlating with acquisition of invasi...

    Mahdi Mojallal, Yujuan Zheng, Sara Hultin, Stéphane Audebert in Nature Communications (2014)

  8. Article

    Open Access

    A Dialogue between the Hypoxia-Inducible Factor and the Tumor Microenvironment

    The hypoxia-inducible factor is the key protein responsible for the cellular adaptation to low oxygen tension. This transcription factor becomes activated as a result of a drop in the partial pressure of oxyge...

    Frédéric Dayan, Nathalie M. Mazure, M. Christiane Brahimi-Horn in Cancer Microenvironment (2008)

  9. No Access

    Article

    Hypoxia signalling in cancer and approaches to enforce tumour regression

    Tumour cells emerge as a result of genetic alteration of signal circuitries promoting cell growth and survival, whereas their expansion relies on nutrient supply. Oxygen limitation is central in controlling ne...

    Jacques Pouysségur, Frédéric Dayan, Nathalie M. Mazure in Nature (2006)